In an effort to confront the oft-mentioned costs of drug development, the clinical trials industry has been evolving from its slow paper-based methods and standalone spreadsheets towards automated, cloud-based systems. There has always been a strong focus on study conduct and quality. But as stakeholders are increasingly aware that better study startup (SSU) processes are linked to shorter clinical timelines, the emphasis is shifting in that direction. A paradigm shift is needed in order to eliminate the three evil "e's" — email, Excel, and e-meetings — long associated with starting clinical trials, with the potential to ultimately reduce timelines and improve data quality. The webinar with focus on addressing the inefficiencies associated with the three evil "e's".